SL
LXRX icon

Siren LLC’s Lexicon Pharmaceuticals LXRX Stock Holding History

Siren LLC’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Hold
44,303,518
– – 2.15% 12
2026
Q1 		$69.1M Buy
44,303,518
+5,384,615
+14% +$7.83M 1.92% 14
2025
Q4 		$44.8M Hold
38,918,903
– – 1.34% 25
2025
Q3 		$52.5M Hold
38,918,903
– – 2.06% 14
2025
Q2 		$36.8M Hold
38,918,903
– – 1.9% 15
2025
Q1 		$17.9M Hold
38,918,903
– – 1.01% 26
2024
Q4 		$28.8M Hold
38,918,903
– – 1.27% 24
2024
Q3 		$61.1M Buy
+38,918,903
New +$69.3M 3.05% 9

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Siren LLC's LXRX Position: Q2 2026 in Review

Siren LLC held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 44,303,518 shares worth $106M. The position accounts for 2.15% of the portfolio, ranked #12.

Siren LLC first reported a position in LXRX in Q3 2024 and has held it in 8 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Siren LLC held 44,303,518 shares of Lexicon Pharmaceuticals worth $106M as of Q2 2026.
  • Siren LLC left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
  • Lexicon Pharmaceuticals made up 2.15% of Siren LLC's portfolio in Q2 2026, its #12 holding.
  • Siren LLC first reported a position in Lexicon Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.